GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $58.4 million in its third quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.05.
The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of $1.05 per share.
The biopharmaceutical company posted revenue of $12.4 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $13.3 million.
Theravance Bio shares have decreased 33% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.12, a drop of 29% in the last 12 months.